Therefore, the level of MFSD2a in the maternal blood of GDM mothers could be used as a potential biomarker for the early detection of disturbances in MFSD2a expression during pregnancy and the subsequent consequences on offspring neurodevelopment [57]. Here, MFSD2A is linked to gestational diabetes.